Study S003400

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06790225
Acronym: GINEBRA
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 13
Start: 2025-11-10
Primary completion: 2026-09-17
Lead sponsor: Esbjerg Hospital - University Hospital of Southern Denmark
Conditions: Bone Disease, Metabolic; Diabetes Mellitus, Type 2; Obesity and Obesity-related Medical Conditions
Interventions: OTHER:Glucose-dependent Insulinotropic Polypeptide (GIP)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Serum levels of CTX [During a three day period. With 14-28 days of washout between the two administration methods]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.